PLUS THERAPEUTICS, INC. (PSTV): debt financing — Plus Therapeutics raises ~$3.7M in secured convertible notes, exchanges warrants, and receives $2M CPRIT advance

PLUS THERAPEUTICS, INC.

Issued $3.36M in secured convertible notes and warrants to purchase ~3M shares at $1.12; aggregate proceeds ~$3.7M.
Exchanged $3.19M of existing Series A warrants for new secured convertible exchange notes.
Notes mature Feb 2026, 10% interest, secured by substantially all assets; mandatory conversion if $10M+ qualified financing by March 31, 2025.
Received $2.0M advance from CPRIT as part of existing $17.6M grant.
Registration rights with liquidated damages of 1%/month (12% cap) for filing/effectiveness delays.

item 1.01 item 2.03 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

PLUS THERAPEUTICS, INC. incurred convertible notes of $3,362,251 with certain existing accredited investors at 10% per annum maturing February 13, 2026.

Instrument: convertible notes
Principal: $3,362,251
Counterparty: certain existing accredited investors
Rate: 10% per annum
Maturity: February 13, 2026
Event: incurrence

Exact text from the filing

On February 13, 2025 (the “Closing Date”), Plus Therapeutics, Inc. (the “Company”) entered into a Securities Purchase and Exchange Agreement (the “SPEA”) with certain existing accredited investors (the “Purchasers”). Pursuant to the SPEA, on the Closing Date the Company issued secured convertible promissory notes (the “Funding Notes”) in the aggregate principal amount of $3,362,251 together with common stock purchase warrants (the “Warrants”) to purchase 3,002,009 shares of the Company common stock, par value $0.001 (the “Common Stock”) at an exercise price of $1.12 per share (the “Warrant Exercise Price”).

View on SEC.gov

87 debt financings filed in the last 30 days. Browse all debt financings →

PLUS THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-028151

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.